Yabao Pharmaceutical Group Co Ltd (600351) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Yabao Pharmaceutical Group Co Ltd (600351) has a cash flow conversion efficiency ratio of 0.047x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥129.49 Million ≈ $18.95 Million USD) by net assets (CN¥2.76 Billion ≈ $403.43 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Yabao Pharmaceutical Group Co Ltd for the company's overall valuation and market capitalisation.
Yabao Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (2001–2024)
This chart illustrates how Yabao Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Yabao Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Yabao Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency. Explore cash flow quality index of Yabao Pharmaceutical Group Co Ltd to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Tanla Platforms Limited
NSE:TANLA
|
0.074x |
|
Henan Huaying Agricultural Development Co Ltd
SHE:002321
|
0.036x |
|
Ronglian Group Ltd
SHE:002642
|
-0.030x |
|
Zhejiang Henglin Chair Industry Co Ltd Class A
SHG:603661
|
0.057x |
|
Lsb Industries Inc
NYSE:LXU
|
0.111x |
|
Bank of Kaohsiung Ltd
TW:2836
|
-0.099x |
|
UEM Sunrise Bhd
KLSE:5148
|
0.007x |
|
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited
STU:2TZ
|
-0.009x |
Annual Cash Flow Conversion Efficiency for Yabao Pharmaceutical Group Co Ltd (2001–2024)
The table below shows the annual cash flow conversion efficiency of Yabao Pharmaceutical Group Co Ltd from 2001 to 2024. View current stock price of Yabao Pharmaceutical Group Co Ltd for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥2.89 Billion ≈ $423.62 Million |
CN¥471.69 Million ≈ $69.02 Million |
0.163x | -1.98% |
| 2023-12-31 | CN¥2.99 Billion ≈ $438.01 Million |
CN¥497.55 Million ≈ $72.81 Million |
0.166x | +8.54% |
| 2022-12-31 | CN¥3.01 Billion ≈ $439.97 Million |
CN¥460.46 Million ≈ $67.38 Million |
0.153x | +3.74% |
| 2021-12-31 | CN¥2.96 Billion ≈ $433.67 Million |
CN¥437.50 Million ≈ $64.02 Million |
0.148x | +9.21% |
| 2020-12-31 | CN¥2.82 Billion ≈ $412.41 Million |
CN¥380.96 Million ≈ $55.75 Million |
0.135x | -13.38% |
| 2019-12-31 | CN¥2.72 Billion ≈ $398.67 Million |
CN¥425.17 Million ≈ $62.22 Million |
0.156x | +10.21% |
| 2018-12-31 | CN¥3.01 Billion ≈ $440.86 Million |
CN¥426.60 Million ≈ $62.43 Million |
0.142x | +155.17% |
| 2017-12-31 | CN¥2.91 Billion ≈ $426.47 Million |
CN¥161.73 Million ≈ $23.67 Million |
0.055x | -2.85% |
| 2016-12-31 | CN¥2.73 Billion ≈ $399.54 Million |
CN¥155.95 Million ≈ $22.82 Million |
0.057x | +6.62% |
| 2015-12-31 | CN¥2.68 Billion ≈ $391.88 Million |
CN¥143.47 Million ≈ $20.99 Million |
0.054x | -45.42% |
| 2014-12-31 | CN¥1.82 Billion ≈ $266.31 Million |
CN¥178.63 Million ≈ $26.14 Million |
0.098x | +193.10% |
| 2013-12-31 | CN¥1.70 Billion ≈ $248.21 Million |
CN¥56.80 Million ≈ $8.31 Million |
0.033x | +155.92% |
| 2012-12-31 | CN¥1.62 Billion ≈ $236.39 Million |
CN¥-96.73 Million ≈ $-14.15 Million |
-0.060x | -270.37% |
| 2011-12-31 | CN¥1.16 Billion ≈ $169.56 Million |
CN¥40.73 Million ≈ $5.96 Million |
0.035x | +89.80% |
| 2010-12-31 | CN¥1.00 Billion ≈ $146.71 Million |
CN¥18.57 Million ≈ $2.72 Million |
0.019x | -95.48% |
| 2009-12-31 | CN¥899.55 Million ≈ $131.63 Million |
CN¥368.56 Million ≈ $53.93 Million |
0.410x | +230.61% |
| 2008-12-31 | CN¥830.32 Million ≈ $121.50 Million |
CN¥102.90 Million ≈ $15.06 Million |
0.124x | -55.43% |
| 2007-12-31 | CN¥380.08 Million ≈ $55.62 Million |
CN¥105.69 Million ≈ $15.47 Million |
0.278x | +702.54% |
| 2006-12-31 | CN¥334.54 Million ≈ $48.95 Million |
CN¥11.59 Million ≈ $1.70 Million |
0.035x | -53.49% |
| 2005-12-31 | CN¥354.37 Million ≈ $51.86 Million |
CN¥26.40 Million ≈ $3.86 Million |
0.074x | -68.41% |
| 2004-12-31 | CN¥338.16 Million ≈ $49.48 Million |
CN¥79.73 Million ≈ $11.67 Million |
0.236x | +879.94% |
| 2003-12-31 | CN¥318.26 Million ≈ $46.57 Million |
CN¥-9.62 Million ≈ $-1.41 Million |
-0.030x | -134.57% |
| 2002-12-31 | CN¥277.81 Million ≈ $40.65 Million |
CN¥24.29 Million ≈ $3.55 Million |
0.087x | -65.96% |
| 2001-12-31 | CN¥91.84 Million ≈ $13.44 Million |
CN¥23.59 Million ≈ $3.45 Million |
0.257x | -- |
About Yabao Pharmaceutical Group Co Ltd
Yabao Pharmaceutical Group Co., Ltd researches, develops, manufactures, and sells Chinese and Western medicines, and pharmaceutical packaging materials in China and internationally. It provides pediatric products, cardiovascular and cerebrovascular products, endocrine products, women's health products, patches, and general health products. Yabao Pharmaceutical Group Co., Ltd was founded in 1978 a… Read more